A5068577679- Lipoproteins and Cardiovascular Health
- Cardiac Imaging and Diagnostics
- Cardiovascular Function and Risk Factors
- Antiplatelet Therapy and Cardiovascular Diseases
- Cardiovascular Disease and Adiposity
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Intracerebral and Subarachnoid Hemorrhage Research
- Cardiac Health and Mental Health
- Acute Myocardial Infarction Research
- Sperm and Testicular Function
- Acute Ischemic Stroke Management
- Heart Failure Treatment and Management
- Cell death mechanisms and regulation
- Health Systems, Economic Evaluations, Quality of Life
- Cardiomyopathy and Myosin Studies
- Cardiac Arrest and Resuscitation
- Muscle and Compartmental Disorders
- Anesthesia and Neurotoxicity Research
- Pharmacology and Obesity Treatment
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Cardiovascular Health and Disease Prevention
- Dermatological and COVID-19 studies
- Cardiac Valve Diseases and Treatments
- Cerebrovascular and Carotid Artery Diseases
- Cardiac Ischemia and Reperfusion
Hospital of the University of Pennsylvania
2021-2024
Pennsylvania Hospital
2021-2024
University of Pennsylvania Health System
2021-2023
University of Pennsylvania
2023
Philadelphia University
2021
Einstein Medical Center Philadelphia
2019
Philadelphia College of Osteopathic Medicine
2018
Abstract Disclosure: D. Vedamurthy: None. M. Ambrosino: K. Suri: Soffer: Jacoby: Background: Observational studies and randomized clinical trials have yielded conflicting data on the role of statins in causing intracerebral hemorrhage. It is unclear whether it safe to continue patients who atherosclerotic cardiovascular disease (ASCVD) when they sustain an hemorrhage (ICH). also not clear this risk ICH (if present) relates statin use or “too low” levels LDL-C. Case: 75-year-old female with...
Preliminary studies in mice have shown that a novel tri‐peptide (Phe‐D‐Arg‐Phe‐Amide, MW=468 g/mol) attenuates ventilation induced diaphragm dysfunction when given as pretreatment. Tri‐peptide is structurally similar to the SS‐20 peptide (Phe‐D‐Arg‐Phe‐Lys‐Amide), which has been be cardioprotective before ischemia, but thought not opioid properties (Cho et al., 2007). Our study aims determine whether pre‐ or posttreatment with more efficacious attenuating deleterious effects of myocardial...
Introduction: Guideline directed lipid therapy (GDLT) for patients following acute coronary syndrome (ACS) is well-established secondary prevention. Historically disparities in prevention have been observed among minority populations, however there limited understanding of GDLT and resultant impact on achieving optimal LDL levels. Hypothesis: may not proportionally result achievement <70 mg/dL. Methods: A cross-sectional study was employed across all University Pennsylvania Health System...
Introduction: Initiation of high intensity statin therapy for patients following acute coronary syndrome (ACS) is well-established secondary prevention. Females with artery disease have historically been associated lower rates goal directed medical therapy. Hypothesis: Disparities in prescriptions and targeted reductions LDL levels exist between genders. Methods: A cross-sectional study was employed across the University Pennsylvania Health System from 2018 to 2019. Electronic records were...
Introduction: Initiation of guideline directed lipid therapy (GDLT) for patients following acute coronary syndrome (ACS) is a well-established secondary prevention. Despite this, variable prescriber adherence to GDLT has been observed and it not well understood how this impacts achievement optimal LDL across gender racial groups. Hypothesis: Gender disparities in subsequent <70 mg/dL exist. Methods: A cross-sectional study was employed University Pennsylvania Health System from 2018 2019....